Search results for " Systemic"

showing 10 items of 201 documents

Manometrische untersuchungen zur oesophagusbeteiligung bei progressiver sklerodermie

1975

Bei 15 Patienten mit progressiver Sklerodermie wurde die Oesophagus funktion manometrisch und radiologisch untersucht. Nur ein Drittel der Patienten gab Schluckbeschwerden an. Dagegen liesen sich radiologisch bei 8 Patienten (55%) deutliche Motilitatsstorungen nachweisen, mit der Oesophagusmanometrie sogar bei 11 Patienten (73%). Fehlende subjektive Symptome schliesen demnach einen ausgedehnten Befall der Speiserohre nicht aus. Die manometrischen Messungen zeigen, das mit einer Beteiligung der Speiserohre im odematos-indurativen Stadium der Sklerodermie in einem wesentlichen hoheren Prozentsatz gerechnet werden mus, als ublicherweise aufgrund von Rontgenuntersuchungen allein angenommen wurd…

Gynecologymedicine.medical_specialtybusiness.industryMedicineProgressive systemic sclerosisDermatologyGeneral Medicinebusinessmedicine.diseaseArchives for Dermatological Research
researchProduct

Combined homozygous factor H and heterozygous C2 deficiency in an Italian family

1988

Three of four children in a family have homozygous (less than 1% of normal) deficiency of factor H of the complement system and both parents, who are first cousins, are heterozygous for the same defect. The father and two of the H-deficient siblings also have a partial C2 deficiency. One of the children with combined deficiencies is affected by systemic lupus erythematosus with nephritis. No increased susceptibility to infections has been observed in the family. H deficiency is inherited in an autosomal codominant manner and is independently transmitted from C2 deficiency and HLA haplotypes. In the homozygous state it is associated with very low serum concentrations of B and C3, barely demo…

Heterozygotemedicine.medical_specialtyGenetic LinkageImmunologyHLA AntigensInternal medicineComplement C3b Inactivator ProteinsmedicineHumansLupus Erythematosus SystemicImmunology and AllergyChildImmunoelectrophoresisLupus erythematosusComplement component 2business.industryHomozygoteHeterozygote advantageComplement C2Complement deficiencymedicine.diseasePedigreeComplement systemEndocrinologyComplement Factor HFactor HComplement C3bImmunologyProperdinFemalebusinessNephritisComplement Factor BJournal of Clinical Immunology
researchProduct

The holonic approach for flexible production: a theoretical framework

2011

This paper discusses the body of knowledge about Holonic Approach to theoretically demonstrate how Holonic Production System (HPS) can be a convincing choice to overcome the problems of traditional production systems? architectures. Today, enterprises are trying to find ways to manage the growing environmental complexity that is well described by Complex Systems Theory (CST). After the focus on the main problem regarding environmental complexity, the Holonic system and the Holonic Production System will be analyzed. The paper will focus the potential of HPS to adapt and react to changes in the business environment whilst being able to maintain systemic synergies and coordination through the…

Holonic production systems Production agility Complex systems Systemic approachSettore SECS-P/08 - Economia E Gestione Delle Imprese
researchProduct

Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basem…

2007

Increased expression of Goodpasture antigen-binding protein (GPBP), a protein that binds and phosphorylates basement membrane collagen, has been associated with immune complex-mediated pathogenesis. However, recent reports have questioned this biological function and proposed that GPBP serves as a cytosolic ceramide transporter (CERTL). Thus, the role of GPBP in vivo remains unknown. New Zealand White (NZW) mice are considered healthy animals although they convey a genetic predisposition for immune complex-mediated glomerulonephritis. Here we show that NZW mice developed age-dependent lupus-prone autoimmune response and immune complex-mediated glomerulonephritis characterized by elevated GP…

Immunoglobulin ACollagen Type IVAgingMice Inbred StrainsMice TransgenicAntigen-Antibody ComplexProtein Serine-Threonine Kinasesurologic and male genital diseasesPathology and Forensic MedicinePathogenesisType IV collagenMiceGlomerulonephritisSpecies SpecificityGlomerular Basement MembranemedicineGoodpasture syndromeAnimalsHumansLupus Erythematosus SystemicAutoantibodiesAutoimmune diseaseBasement membranebiologyGlomerular basement membraneGlomerulonephritismedicine.diseaseImmunoglobulin Amedicine.anatomical_structureImmunologyCancer researchbiology.proteinRegular Articles
researchProduct

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)

2020

The B cell activating factor (BAFF), or B lymphocyte stimulator (BLyS), is a B cell survival factor which supports autoreactive B cells and prevents their deletion. BAFF expression is closely linked with autoimmunity and is enhanced by genetic alterations and viral infections. Furthermore, BAFF seems to be involved in adipogenesis, atherosclerosis, neuro-inflammatory processes and ischemia reperfusion (I/R) injury. BAFF is commonly overexpressed in Systemic Lupus Erythematosus (SLE) and strongly involved in the pathogenesis of the disease. The relationship between BAFF levels, disease activity and damage accrual in SLE is controversial, but growing evidence is emerging on its role in renal …

ImmunologyAutoimmunitymedicine.disease_causeAutoimmunityPathogenesisImmune systemstomatognathic systemimmune system diseaseshemic and lymphatic diseasesB-Cell Activating FactormedicineHumansLupus Erythematosus SystemicImmunology and Allergyskin and connective tissue diseasesB-cell activating factorB cellB-LymphocytesSystemic lupus erythematosusbusiness.industrymedicine.diseaseBelimumabstomatognathic diseasesmedicine.anatomical_structureVirus DiseasesImmunologyRituximabbusinessmedicine.drugAutoimmunity Reviews
researchProduct

Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome.

2008

Objective To review the current evidence regarding the relationship between systemic lupus erythematosus (SLE) and antiphospholipid syndrome and female infertility, as well as the risks associated with ovarian stimulation for ovulation induction and IVF. To establish, based on this information, guidelines for safe and successful assisted reproductive technology (ART). Design A MEDLINE computer search was performed to identify relevant articles. Result(s) Systemic lupus erythematosus and antiphospholipid syndrome are not related to infertility, except for cases of amenorrhea accompanying severe flares, renal insufficiency-related hypofertility, and ovarian failure secondary to cyclophosphami…

Infertilitymedicine.medical_specialtymedicine.medical_treatmentOvarian hyperstimulation syndromeFertilization in VitroOvulation Inductionimmune system diseasesAntiphospholipid syndromePregnancyRisk FactorsmedicineHumansLupus Erythematosus Systemicskin and connective tissue diseasesIn vitro fertilisationLupus erythematosusSystemic lupus erythematosusbusiness.industryObstetricsFemale infertilityObstetrics and Gynecologymedicine.diseaseAntiphospholipid SyndromeReproductive MedicineImmunologyOvulation inductionFemalebusinessInfertility FemaleFertility and sterility
researchProduct

Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.

2004

Primary defence against invading microorganisms depends on a functional innate immune system and the complement system plays a major role in such immunity. Deficiencies in one of the components of the complement system can cause severe and recurrent infections, systemic diseases, such as systemic lupus erythematosus (SLE) and renal disease. Screening for complement deficiencies in the classical or alternative complement pathways has mainly been performed by haemolytic assays. Here, we describe a simple ELISA-based format for the evaluation of three pathways of complement activation. The assays are based on specific coatings for each pathway in combination with specific buffer systems. We ha…

Innate immune systemSystemic lupus erythematosusImmunologyComplement Pathway AlternativeComplement Pathway Mannose-Binding LectinEnzyme-Linked Immunosorbent AssayComplement System ProteinsBiologyComplement fixation testmedicine.diseaseMannose-Binding LectinComplement systemComplement (complexity)Immune systemImmunologymedicineImmunology and AllergyHumansLupus Erythematosus SystemicComplement Pathway ClassicalReagent Kits DiagnosticFicolinComplement ActivationMannan-binding lectinJournal of immunological methods
researchProduct

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.

2021

While COVID-19 infection and mortality rates are soaring in Western countries, Southeast Asian countries have successfully avoided the second wave of the SARS-CoV-2 pandemic despite high population density. We provide a biochemical hypothesis for the connection between low COVID-19 incidence, mortality rates, and high visceral adiposity in Southeast Asian populations. The SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) as a gateway into the human body. Although the highest expression levels of ACE2 are found in people’s visceral adipose tissue in Southeast Asia, this does not necessarily make them vulnerable to COVID-19. Hypothetically, high levels of visceral adiposity cause s…

Intra-Abdominal FatHealth Toxicology and Mutagenesislcsh:MedicinePhysiologyAdipose tissueACE2030209 endocrinology & metabolismIntra-Abdominal FatPeptidyl-Dipeptidase ASoutheast asianSystemic inflammationWhite People03 medical and health sciences0302 clinical medicineAsian PeopleMedicineHumansObesityvisceral adipose tissuePandemicsAsia Southeastern030304 developmental biologyAdiposityInflammationsystemic inflammation0303 health sciencesbusiness.industrySARS-CoV-2Mortality rateIncidencelcsh:RCOVID-19 ; visceral adipose tissue ; systemic inflammation ; SARS-CoV-2 ; ACE2 ; weight gain ; second wave ; Quarantine-15Public Health Environmental and Occupational HealthCOVID-19weight gainmedicine.diseaseObesitysecond waveQuarantine-15PerspectiveAngiotensin-Converting Enzyme 2medicine.symptombusinessWeight gainObesity paradoxInternational journal of environmental research and public health
researchProduct

A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegene…

1991

Autoantibodies directed against cytoplasmic antigens of neutrophils (ANCA), especially proteinase 3 (C-ANCA), have proved to be a useful clinical tool to support the diagnosis or to monitor disease activity in Wegener's granulomatosis (WG). Till now, human neutrophil granulocytes have represented the major antigen source used to detect antibodies in WG by the immunofluorescence technique (IFT). We have tested serum samples of 164 patients with different connective tissue diseases (50 suffering from clinically active WG) performing IFT on a human renal cancer line (SK-RC11) and have found antibodies against the nuclear and cytoplasmic antigens in 39 patients. C-ANCA+ sera displayed a charact…

Liver CirrhosisTime Factorsmedicine.drug_classNeutrophilsImmunologyBlotting WesternFluorescent Antibody TechniqueImmunofluorescenceMonoclonal antibodyAutoantigensMonocytesSerologyCell LineArthritis RheumatoidScleroderma LocalizedAntigenProteinase 3medicineImmunology and AllergyHumansLupus Erythematosus SystemicAnti-neutrophil cytoplasmic antibodyAutoantibodiesMixed Connective Tissue Diseasemedicine.diagnostic_testbiologyTumor Necrosis Factor-alphaGranulomatosis with PolyangiitisBiological Transportmedicine.diseaseVirologyMolecular biologyKidney NeoplasmsSjogren's SyndromeAntibodies Antinuclearbiology.proteinInterferonsAntibodyGranulomatosis with polyangiitisGranulocytesJournal of immunological methods
researchProduct

Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function

2022

The number of effective systemic therapies for the treatment of advanced hepatocellular carcinoma (HCC) is rapidly increasing, and the advent of immunotherapy has changed the treatment paradigm for these patients, leading to significantly improved survival outcomes. However, many patients with HCC will continue to receive tyrosine kinase inhibitors, partly because of contraindications to immune checkpoint inhibitors. Currently, the best sequential first- and second-line systemic treatment remains elusive. Maintenance of optimal liver function is crucial, it is likely to impinge on temporary or permanent treatment discontinuation, and should also be considered when defining the treatment seq…

Liver CirrhosisTyrosine kinase inhibitorsSettore MED/12 - GastroenterologiaCarcinoma HepatocellularHepatologyDecompensation Free Survival; Hepatocellular carcinoma; Immune checkpoint inhibitor; Overall Survival; Progression Free Survival; Systemic therapies; Time to Decompensation; Time to Progression; Tyrosine kinase inhibitorsSystemic therapieHepatocellular carcinomaOverall SurvivalDecompensation Free SurvivalLiver NeoplasmsGastroenterologyTime to DecompensationTyrosine kinase inhibitorSystemic therapiesImmune checkpoint inhibitorTime to ProgressionProgression Free SurvivalHumansImmunotherapy
researchProduct